Analysis & Opinions
February 08, 2013
Vical Inc. (VICL) suffered a net loss per share of 9 cents in the fourth quarter of 2012, narrower than the Zacks ...
January 17, 2013
Amarin Corporation plc (AMRN), recently announced that the notice of patent allowance for US application serial ...
January 16, 2013
Ironwood Pharmaceuticals, Inc.'s (IRWD) fourth-quarter 2012 loss of 41 cents per share compared unfavorably with the ...
January 02, 2013
Aeterna Zentaris Inc. (AEZS) recently announced that its oncology candidate, AEZS-108 (doxorubicin peptide ...
August 17, 2011
In the wake of big pharma's patent cliff and slowing R&D spending, the biotech sector is looking good for investors.
May 27, 2010
ASCO is a major event for the pharmaceutical and biotech industry, and these stocks could shine in the limelight.